<DOC>
	<DOC>NCT01050374</DOC>
	<brief_summary>This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of MBD in combination with PZQ in the treatment of SCH and STH in children aged 1-15 years of age.</brief_summary>
	<brief_title>Safety and Efficacy of Drug Combinations Against Schistosomiasis</brief_title>
	<detailed_description />
	<mesh_term>Parasitic Diseases</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<mesh_term>Mebendazole</mesh_term>
	<mesh_term>Piperazine</mesh_term>
	<mesh_term>Piperazine citrate</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Those with an age of 115 years of age Are infected with schistosomiasis and soiltransmitted helminthiasis Whose parent consent and who are willing to participate Those with acute and chronic diseases other than schistosomiasis and soiltransmitted helminthiasis Those with a history of any serious adverse drug reactions</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>